Digital Pathology Market

The global digital pathology market is projected to reach USD 2.86 billion by 2031 from USD 1.58 billion in 2026, at a CAGR of 12.5% from 2026 to 2031. The primary driver of this increase is the growing need to enhance diagnostic efficiency, accuracy, and workflow productivity across hospitals, diagnostic laboratories, and research institutions.

The major players operating in this market are Danaher Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), Koninklijke Philips N.V. (Netherlands), Sectra AB (Sweden), Hamamatsu Photonics (Japan), Fujifilm Holdings Corporation (Japan), Quanterix (US), Hologic, Inc. (US), 3DHISTECH (Hungary), Apollo Enterprise Imaging Corp.(US), Huron Technologies International Inc (Canada), Indica Labs, LLC (US), OptraSCAN (US), Glencoe Software, Inc. (US), Aiforia (Finland), Paige AI, Inc. (US), Proscia Inc. (US), Evident (Japan), PathAI, Inc (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD. (China), Mikroscan Technologies, Inc. (US), Motic Digital Pathology (US), Morphle Labs Inc. (US), Grundium Oy (Finland), and Curiosis Inc. (South Korea).

To know about the assumptions considered for the study download the pdf brochure

In January 2026, Leica Biosystems launched the Aperio CS5 scanner, a compact device designed to support digital transformation, offering researchers a powerful, low- to medium-volume, high-quality whole-slide imaging system. In January 2025, Roche obtained FDA 510(k) clearance for its Digital Pathology Dx system, which now includes the high-capacity VENTANA DP 600 slide scanner. Roche also secured US FDA clearance for its VENTANA DP 200 in June 2024.

Danaher Corporation

Danaher Corporation is one of the leading providers of life sciences, diagnostics, and digital pathology solutions through its operating companies, including Leica Biosystems. The company serves hospitals, diagnostic laboratories, academic medical centers, and pharmaceutical and biotechnology organizations worldwide. Through its digital pathology portfolio, Danaher supports pathology workflow digitization, cancer diagnostics, companion diagnostics development, and precision medicine initiatives. The company focuses on continuous innovation, strategic acquisitions, and the integration of advanced technologies. Leica Biosystems' digital pathology platform enables pathologists to improve diagnostic accuracy, enhance workflow efficiency, and facilitate remote collaboration through telepathology applications.

F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd. is a global healthcare company that operates in pharmaceuticals and diagnostics. The company provides a wide range of diagnostic solutions through its diagnostics business, including digital pathology systems, companion diagnostics, tissue diagnostics, and AI-enabled pathology tools. Roche serves hospitals, diagnostic laboratories, research institutes, and pharmaceutical companies across more than 100 countries. The company has a strong global presence through its subsidiaries, research centers, manufacturing facilities, and distribution networks. The company has collaborated with several AI and software companies to develop advanced image analysis solutions that support cancer diagnosis and biomarker assessment. These efforts help improve diagnostic accuracy, workflow efficiency, and clinical decision-making.

Koninklijke Philips N.V.

Koninklijke Philips N.V. is a global health technology company that provides healthcare IT, medical imaging, and digital pathology solutions to hospitals, diagnostic laboratories, and research organizations worldwide. In digital pathology, Philips offers end-to-end solutions that include whole-slide imaging, image management systems, cloud-based collaboration tools, and AI-enabled pathology software. The company focuses on improving diagnostic efficiency, supporting remote pathology workflows, and enabling better clinical decision-making. Philips has strengthened its position in the digital pathology market through continuous product innovation and integration of advanced technologies such as artificial intelligence, cloud computing, and advanced visualization tools. Its digital pathology platforms are designed to support faster diagnosis, enable telepathology, and improve collaboration between pathologists across different locations.

Market Ranking

Companies such as Danaher Corporation, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Sectra AB are considered the leading players in the digital pathology market. These companies hold strong market positions due to their broad product portfolios, including digital scanners, imaging platforms, and integrated pathology workflow solutions. They are widely adopted by large hospitals, diagnostic laboratories, and research institutes because they provide end-to-end digital pathology ecosystems that combine imaging, data management, and AI-based analysis. Roche is more focused on diagnostics and laboratory workflow solutions rather than full enterprise imaging platforms. Sectra AB has a strong presence in medical imaging and secure pathology IT systems. Sectra is particularly strong in Europe and is known for its secure image management, radiology-pathology integration, and hospital IT solutions.

Related Reports:

Digital Pathology Market by Product (Brightfield Scanner, Enterprise Software, Storage System), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), Indication (Onco, Hemo), End User (Pharma & Biotech, Hospital) Al- Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]